Notify me when Peter Fernandes files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics, Inc. | Chief Executive Officer, Principal Financial and Accounting Officer | $154,337 | 07 Jun 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|